NID1 and neoplasm: While shRNA to Hspg2 barely affected neutrophil cytotoxicity, shRNA to Nidogen-1 reduced tumor cell susceptibility to neutrophil cytotoxicity, suggesting that Nidogen-1 contributes to the neutrophil recognition of tumor cells required for the subsequent cytotoxic effect.